Human liver stem-cell-derived extracellular vesicles (HLSC-EVs) exhibit therapeutic
properties in various pre-clinical models of kidney injury. We previously reported an overall …

It is well‐accepted that hepatic stellate cells (HSCs) can develop into myofibroblast‐like cells
that synthesize extracellular matrix proteins and contribute to liver fibrosis. Recently …

Hepatic stellate cells (HSCs) play an essential role in various liver diseases, and exosomes
are critical mediators of intercellular communication in local and distant microenvironments …

The potential therapeutic effect of extracellular vesicles (EVs) that are derived from human
liver stem cells (HLSCs) has been tested in an in vivo model of renal ischemia and …

Hepatic ischemia reperfusion injury (IRI) remains a major obstacle in liver resection and
transplantation surgery, especially in diseased organs. Human mesenchymal stromal cells …

Transplantation of bone marrow derived stem cells (BMSCs) has been reported inhibits liver
fibrosis. Several in vitro studies by co-culturing BMSCs and hepatic stellate cells (HSCs) …

Various somatic tissue‐derived mesenchymal stromal cells (MSCs) have been considered
as an attractive therapeutic tool for treatment of liver diseases in which the secretion of …

Abstract Background Mesenchymal stem cells (MSCs) are considered to be a potential
therapeutic tool for liver fibrosis. Inhibiting the activation of hepatic stellate cells (HSCs) and …

Mesenchymal stem cells (MSCs), as the most common cell source for stem cell therapy, play
an important role in the modulation of innate and adaptive immune responses and have …

Normal liver sinusoidal endothelial cells (LSECs) promote quiescence of hepatic stellate
cells (HSCs). Prior to fibrosis, LSECs undergo capillarization, which is permissive for HSC …